PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

AHA Scientific Statement on Caffeine and Cardiovascular Disease

AHA Scientific Statement on Caffeine and Cardiovascular DiseaseAmerican Heart Associationcardiovascular diseasecaffeinecoffeeenergy drinks Cardiology

Background Information

Caffeine's cardiovascular effects vary from coffee's benefits to energy drinks' risks.

Understanding caffeine's effects on cardiovascular health is crucial given its widespread consumption globally. Moderate caffeine intake, especially from coffee, is associated with a lower risk of stroke and atrial fibrillation, but high caffeine doses found in energy drinks may pose cardiovascular risks. This guideline helps clarify caffeine's impact on cardiovascular health, highlighting potential benefits of moderate coffee consumption and risks of high-dose caffeine products. Moderate coffee consumption may reduce stroke and atrial fibrillation risks, but high caffeine doses can be harmful.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Marcus GM, Hu FB, van Dam RM, Cornelis MC, Dewland TA, Kang J, Larsson SC, Page RL 2nd, Parekh N, American Heart Association Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Stroke Council

Citation: Marcus GM, Hu FB, van Dam RM, et al. Caffeine and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2026;154(9):e345-e355. doi:10.1161/CIR.0000000000001454

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.